124 related articles for article (PubMed ID: 8115278)
1. Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma.
Bloch WE; Lokeshwar BL; Ferrell SM; Block NL
Prostate; 1994; 24(3):131-8. PubMed ID: 8115278
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 prostate carcinoma cells.
Roigas J; Wallen ES; Loening SA; Moseley PL
Prostate; 1998 Feb; 34(3):195-202. PubMed ID: 9492848
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of radiation response of prostatic carcinoma by lonidamine.
Dudak SD; Lopez A; Block NL; Lokeshwar BL
Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
[TBL] [Abstract][Full Text] [Related]
4. Interaction of irradiation and microwave-induced hyperthermia in the Dunning R3327G prostatic adenocarcinoma model.
Gottlieb CF; Seibert GB; Block NL
Radiology; 1988 Oct; 169(1):243-7. PubMed ID: 3420266
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
6. Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
Floridi A; Gentile FP; Bruno T; Delpino A; Iacobini C; Paggi MG; Castiglione S; Benassi M
Oncol Res; 1993; 5(1):1-10. PubMed ID: 8369571
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
Ning SC; Hahn GM
Cancer Res; 1991 Nov; 51(21):5910-4. PubMed ID: 1718588
[TBL] [Abstract][Full Text] [Related]
8. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
Lokeshwar BL; Hurkadli KS; Sheth AR; Block NL
Cancer Res; 1993 Oct; 53(20):4855-9. PubMed ID: 8402673
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.
Nakata B; Chung YS; Yokomatsu H; Sawada T; Kubo T; Kondo Y; Satake K; Sowa M
Jpn J Cancer Res; 1992 May; 83(5):477-82. PubMed ID: 1618697
[TBL] [Abstract][Full Text] [Related]
10. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
11. Whole-body hyperthermia and lonidamine as adjuvant therapy to treatment with cisplatin with or without local radiation in mouse bearing the Lewis lung carcinoma.
Teicher BA; Holden SA; Ara G; Menon K
Int J Hyperthermia; 1995; 11(5):637-45. PubMed ID: 7594815
[TBL] [Abstract][Full Text] [Related]
12. Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.
Cavaliere R; Di Filippo F; Varanese A; Carlini S; Calabro A; Aloe L; Piarulli L
Oncology; 1984; 41 Suppl 1():116-20. PubMed ID: 6717890
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft.
Pratesi G; De Cesare M; Zunino F
Cancer Chemother Pharmacol; 1996; 38(2):123-8. PubMed ID: 8616901
[TBL] [Abstract][Full Text] [Related]
14. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic enhancement of low dose-rate irradiation in human lung cancer cells by mild hyperthermia.
Sakurai H; Mitsuhashi N; Kitamoto Y; Nonaka T; Harashima K; Higuchi K; Muramatsu H; Ebara T; Ishikawa H; Niibe H
Anticancer Res; 1998; 18(4A):2525-8. PubMed ID: 9703904
[TBL] [Abstract][Full Text] [Related]
16. Systematic investigation into interaction of ionizing radiation and doxorubicin in the Dunning R3327G prostatic adenocarcinoma model.
Gottlieb CF; Seibert GB; Block NL
NCI Monogr; 1988; (6):147-53. PubMed ID: 3352758
[TBL] [Abstract][Full Text] [Related]
17. Supraphysiological thermal injury in Dunning AT-1 prostate tumor cells.
Bhowmick S; Swanlund DJ; Bischof JC
J Biomech Eng; 2000 Feb; 122(1):51-9. PubMed ID: 10790830
[TBL] [Abstract][Full Text] [Related]
18. Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo.
Kim JH; Kim SH; Alfieri A; Young CW; Silvestrini B
Oncology; 1984; 41 Suppl 1():30-5. PubMed ID: 6717892
[TBL] [Abstract][Full Text] [Related]
19. Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo.
Zagaja GP; Shrivastav M; Fleig MJ; Marton LJ; Rinker-Schaeffer CW; Dolan ME
Cancer Chemother Pharmacol; 1998; 41(6):505-12. PubMed ID: 9554596
[TBL] [Abstract][Full Text] [Related]
20. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
